Related Experiment Video
Updated: Jan 26, 2026
06:05
A BW Reporter System for Studying Receptor-Ligand Interactions
Published on: January 7, 2019
8.1K
Use of defined-function mutants to access receptor-receptor interactions
ChangWoo Lee1, Inhae Ji Ji, Tae H Ji
1Department of Chemistry, University of Kentucky, 40506-0055, Lexington, KY, USA
Methods (San Diego, Calif.)
|September 10, 2002
Summary
Researchers developed a new method to study defective G-protein-coupled receptors by coexpressing mutants. This revealed functional interactions and rescued receptor activity, offering insights into hormone receptor mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- G-protein-coupled receptors (GPCRs) mediate cellular responses to hormones.
- Luteinizing hormone receptor (LHR) is a key GPCR involved in reproductive functions.
- Understanding GPCR functional interactions is crucial for drug development.
Purpose of the Study:
- To develop a novel method for assessing functional interactions between defective mutant receptors.
- To investigate the mechanisms of luteinizing hormone receptor (LHR) activation.
- To explore implications for treating inherited glycoprotein hormone receptor disorders.
Main Methods:
- Coexpression of two distinct LHR mutants: one defective in hormone binding and another in signal generation.
- Assessing cellular response to hormone upon coexpression.
- Analyzing intramolecular (cis-activation) and intermolecular (trans-activation) receptor activation pathways.
Main Results:
- Coexpression of defective LHR mutants rescued receptor activity, demonstrating functional interaction.
- Hormone binding to one receptor mutant activated adenylyl cyclase via cis- and trans-activation pathways.
- Functional receptor interactions occurred without the formation of stable receptor dimers.
Conclusions:
- A novel method was established to study functional interactions of defective GPCRs.
- Receptor activation can occur through intermolecular mechanisms (trans-activation) between non-dimeric receptors.
- Findings provide new insights into GPCR activation and potential therapeutic strategies for related disorders.
Related Concept Videos
01:29Drug-Receptor Interactions
7.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.4K
01:31Internal Receptors
74.4K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.4K
01:39Receptor-mediated Endocytosis
110.7K
Overview
110.7K
01:28Drug-Receptor Interaction: Antagonist
5.0K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
5.0K
01:25Drug-Receptor Interaction: Agonist
4.1K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K
01:21G-protein Coupled Receptors
131.7K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.7K